Search
for

    Products matching "androgen concentration"

    Tracking 1 products like 265 RU-58841 Solution 50mg/ml – 50ml from by companies like Chemyo. View product »
    Sort by

    Research

    990-1000 / 1000+ results
      Medical Management Options for Hair Loss

      research Medical Management Options for Hair Loss

      July 2011 in “Springer eBooks”
      The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.
      Prostate Cancer Update: 2007

      research Prostate Cancer Update: 2007

      August 2008 in “Current Opinion in Internal Medicine”
      In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.
      Main Plenary Sessions: Summaries of Papers

      research Main Plenary Sessions: Summaries of Papers

      June 2008 in “British Journal of Dermatology”
      UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.
      A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case

      research A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case

      March 2023 in “Bagcılar medical bulletin”
      A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.
      Table 1

      research Table 1

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.
      Table 2

      research Table 2

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.